Progression of parkinsonian signs in Alzheimer's disease

Neurology

Volumn 54, Issue 6, 2000, Pages 1284-1289

  Wilson, Robert S ^a   Bennett, D A ^a   Gilley, D W ^a   Beckett, L A ^a   Schneider, J A ^a   Evans, D A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AD; Longitudinal study; Parkinsonism

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRADYKINESIA; DISEASE COURSE; FEMALE; GAIT DISORDER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MUSCLE RIGIDITY; PARKINSONISM; PRIORITY JOURNAL; TREMOR;

EID: 0034724148     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.6.1284     Document Type: Article

References (36)

1. Chui H, Teng E, Henderson V, Moy A. Clinical subtypes of dementia in Alzheimer's disease. Neurology 1985;35:1544-1550.
2. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of Alzheimer's type: evidence for subgroups. Neurology 1985;35: 453-461.
3. Chui H, Lyness S, Sobel E, Schneider L. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Arch Neurol 1994;51:676-681.
4. Miller T, Tinklenberg J, Brooks J, Yesavage J. Cognitive decline in patient's with Alzheimer's disease: differences in patients with and without extrapyramidal signs. Alzheimer Dis Assoc Disord 1991;5:251-256.
5. Morris J, Drazner M, Fulling K, Grant E, Goldring J. Clinical and pathological aspects of parkinsonism in Alzheimer's disease. Arch Neurol 1989;46:651-657.
6. Stern Y, Mayeux R, Sano M, Hauser W, Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology 1987;37:1649-1653.
7. Stern Y, Albert M, Brandt J, et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: Prospective analyses from the predictors study. Neurology 1994;44:2300-2307.
8. Mortimer J, Ebbitt B, Jun S-P, Finch M. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 1992;42:1689-1696.
9. Stern Y, Liu X, Albert M, et al. Modeling the influence of extrapyramidal signs on the progression of Alzheimer's disease. Arch Neurol 1996;53:1121-1126.
10. Bennett D, Beckett L, Wilson R, Murray A, Evans D. Parkinsonian signs and mortality from Alzheimer's disease. Lancet 1998;351:1631. Letter.
11. Burns A, Jacoby R, Levy R. Neurological signs in Alzheimer's disease. Age Ageing 1991;20:45-51.
12. Cory-Bloom J, Galasko D, Hofstetter R, Jackson J, Thai L. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. J Am Geriatr Soc 1993;41:31-37.
13. Lopez O, Wisnieski S, Becker J, Boller F, DeKosky S. Extra-pyramidal signs in patients with probable Alzheimer's disease. Arch Neurol 1997;54:969-975.
14. Snowden M, Bowen J, Hughes J, Larson E. Study of Alzheimer's dementia patients with parkinsonian features. J Geriatr Psychiatry Neurol 1995;8:154-158.
15. Drachman D, O'Donnell B, Lew R, Swearer J. The prognosis in Alzheimer's disease: "how far" rather than "how fast" best predicts the course. Arch Neurol 1990;47:851-856.
16. Ellis R, Caligiuri M, Galasko D, Thal L. Extrapyramidal motor signs in clinically diagnosed Alzheimer's disease. Alzheimer Dis Assoc Disord 1996;10:103-114.
17. Fahn S, Elton R. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Goldstein M, et al., eds. Recent developments in Parkinson's disease, vol 12. Florham Park, NJ: MacMillan Healthcare, 1987:153-163.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
19. Folstein M, Folstein S, McHugh P. Mini-Mental State. A practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20. Wilson R, Gilley D, Bennett D, Beckett L, Evans D. Personspecific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychology and Aging (in press).
21. Medi-Span, Inc. Master drug database documentation manual. Indianapolis, IN: Medi-Span, Inc., 1995.
22. Mirra S, Hart M, Terry R. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Path Lab Med 1993;117:132-144.
23. Clark C, Ewbank D, Lerner A, et al. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD study. Neurology 1997;49:70-75.
24. Bennett D, Shannon K, Beckett L, Goetz C, Wilson R. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology 1997;49:1580-1586.
25. Bennett D, Shannon K, Beckett L, Wilson R. Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J Gerontol: Med Sci 1999;54A:M191-M196.
26. Laird N, Ware J. Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
27. Chen J-Y, Stern Y, Sano M, Mayeux R. Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol 1991;48:1141-1143.
28. Soininen H, Laulumaa V, Helkala E, Hartikainen P, Riekkinen P. Extrapyramidal signs in Alzheimer's disease: a 3-year follow-up study. J Neural Transm 1992;4:107-119.
29. Webster D. Clinical analysis of the disability in Parkinsonism disease. Mod Treat 1968;5:257-282.
30. Bennett D, Beckett L, Murray A, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996;334:71-76.
31. Richards M, Stern Y, Marder K, Cote L, Mayeux R. Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals. Neurology 1993;33:267-274.
32. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 1993;43:2184-2188.
33. Gilley D, Wilson R, Bennett D, Bernard B, Fox J. Predictors of behavioral disturbance in Alzheimer's disease. J Gerontol 1991;46:362-371.
34. Richards M, Bell K, Dooneief M, Sano M, Mayeux R, Stern Y. Patterns of neuropsychological performance in Alzheimer's disease patients with and without extrapyramidal signs. Neurology 1993;43:1708-1711.
35. Stern Y, Folstein M, Albert M, et al. Multi-center study of predictors of disease course in Alzheimer's disease (the "Predictors's study"): I. study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord 1993;7:3-21.
36. Louis E, Tang M, Cote L, Alfaro B, Mejia H, Marder K. Progression of parkinsonian signs in Parkinson's disease. Arch Neurol 1999;56:334-337.